- Pharmacokinetic comparison of two valproic acid formulations: a plain and a controlled release enteric-coated tablets
-
Rha JH, Jang IJ, Lee KH, Chong WS, Shin SG, Lee N, Myung HJ
- KMID: 2157507
- J Korean Med Sci.
- 1993 Aug;8(4):251-256.
- doi: 10.3346/jkms.1993.8.4.251
We investigated the single- and multiple dose pharmacokinetics of a new controlled-release formulation (Orfil retard enteric coated tablet) of valproic acid in comparison with those of the plain tablet as... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacokinetics and Safety of Duloxetine Enteric-coated Tablets in Chinese Healthy Volunteers: A Randomized, Open-label, Single- and Multiple-dose Study
-
Li H, Li T, Li Y, Shen Y
- KMID: 2171194
- Clin Psychopharmacol Neurosci.
- 2013 Apr;11(1):28-33.
OBJECTIVE: Duloxetine hydrochloride is a selective serotonin (5-hydroxytryptamine) and norepinephrine reuptake inhibitor. It is approved for effective treatment for major depressive disorder. The pharmacokinetics (PK) of duloxetine has been studied,... -
- CITED
-
- Close
- SHARE
-
- Close
- Cyclosporine Sparing Effect of Enteric-Coated Mycophenolate Sodium in De Novo Kidney Transplantation
-
Lee SH, Park JB, Oh CK, Kim MS, Kim SJ, Ha J
- KMID: 2374209
- Yonsei Med J.
- 2017 Jan;58(1):217-225.
- doi: 10.3349/ymj.2017.58.1.217
PURPOSE: The increased tolerability of enteric-coated mycophenolate sodium (EC-MPS), compared to mycophenolate mofetil, among kidney transplant recipients has the potential to facilitate cyclosporine (CsA) minimization. Therefore, a prospective trial to... -
- CITED
-
- Close
- SHARE
-
- Close
- Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females
-
Mok JO, Jung CH, Kim CH, Ryu CB, Kim YJ, Kim SJ, Park HK, Suh KI, Yoo MH, Byun DW
- KMID: 1780130
- Korean J Intern Med.
- 2013 Nov;28(6):694-700.
- doi: 10.3904/kjim.2013.28.6.694
BACKGROUND/AIMS: This study was performed to compare the mucosal findings after esophagogastroduodenoscopy in two groups before and after the use of alendronate only and following administration of the enteric-coated alendronate... -
- CITED
-
- Close
- SHARE
-
- Close
- Gastroduodenal Injury in Patients with Low-Dose Enteric Coated Aspirin Treatment
-
Lee HL, Han DS, Kim JB, Park JY, Sohn JH, Hahm JS, Ahn YH
- KMID: 881582
- Korean J Gastroenterol.
- 2003 Sep;42(3):190-194.
BACKGROUND/AIMS: Low-dose aspirin therapy is widely used to prevent cardiovascular thrombotic events. However, the safety of low-dose aspirin therapy in the gastrointestinal tract is uncertain. Our aim was to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
- Improved Gastrointestinal Symptoms and Quality of Life after Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus
-
Hwang HS, Hyoung BJ, Kim S, Oh HY, Kim YS, Kim JK, Kim YH, Kim YL, Kim CD, Shin GT, Yang CW
- KMID: 1792900
- J Korean Med Sci.
- 2010 Dec;25(12):1759-1765.
- doi: 10.3346/jkms.2010.25.12.1759
It is reported that a conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) relieves gastrointestinal (GI) symptom burden and improves health-related quality of life (HRQoL). However, it is... -
- CITED
-
- Close
- SHARE
-
- Close
